COVID-19: FAQs—Congenital Heart Surgery Recovery and Defining a “New Normal”

Dearani, Joseph A.; Guleserian, Kristine J.; Overman, David M.; Backer, Carl L.; Romano, Jennifer C.; Louis, James D. St.; Sarris, George E.; Bacha, Emile A.; Tweddell, James S.

doi:10.1177/2150135120934741

Cited by 11 publications

(11 citation statements)

References 20 publications

(46 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition to the increased risk for severe infection, CHD patients are facing the tremendous impact of the pandemic on outpatient visits and surgical programs around the world[ 169 - 172 ]. To minimize SARS-CoV-2 spread, extensive preventive measures are essential for these patients.…”

Section: Resultsmentioning

confidence: 99%

Cardiovascular impact of COVID-19 with a focus on children: A systematic review

Rodríguez-González

Castellano-Martínez

Cascales-Poyatos³

et al. 2020

WJCC

View full text Add to dashboard Cite

BACKGROUND Since the beginning of the pandemic, coronavirus disease-2019 (COVID-19) in children has shown milder cases and a better prognosis than adults. Although the respiratory tract is the primary target for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), cardiovascular involvement is emerging as one of the most significant and life-threatening complications of SARS-CoV-2 infection in adults. AIM To summarize the current knowledge about the potential cardiovascular involvement in pediatric COVID-19 in order to give a perspective on how to take care of them during the current pandemic emergency. METHODS Multiple searches in MEDLINE, PubMed were performed using the search terms “COVID-19” or “SARS-CoV-2" were used in combination with “myocardial injury” or "arrhythmia" or “cardiovascular involvement” or "heart disease" or "congenital heart disease" or “pulmonary hypertension” or "long QT" or “cardiomyopathies” or “channelopathies” or "Multisystem inflammatory system" or "PMIS" or “MIS-C” or ”Pediatric multisystem inflammatory syndrome" or "myocarditis" or "thromboembolism to identify articles published in English language from January 1st, 2020 until July 31st, 2020. The websites of World Health Organization, Centers for Disease control and Prevention, and the Johns Hopkins Coronavirus Resource Center were reviewed to provide up to date numbers and infection control recommendations. Reference lists from the articles were reviewed to identify additional pertinent articles. Retrieved manuscripts concerning the subject were reviewed by the authors, and the data were extracted using a standardized collection tool. Data were subsequently analyzed with descriptive statistics. For Pediatric multisystemic inflammatory syndrome temporally associated with COVID-19 (PMIS), multiple meta-analyses were conducted to summarize the pooled mean proportion of different cardiovascular variables in this population in pseudo-cohorts of observed patients. RESULTS A total of 193 articles were included. Most publications used in this review were single case reports, small case series, and observational small-sized studies or literature reviews. The meta-analysis of 16 studies with size > 10 patients and with complete data about cardiovascular involvement in children with PMIS showed that PMIS affects mostly previously healthy school-aged children and adolescents presenting with Kawasaki disease-like features and multiple organ failure with a focus on the heart, accounting for most cases of pediatric COVID-19 mortality. They frequently presented cardiogenic shock (53%), ECG alterations (27%), myocardial dysfunction (52%), and coronary artery dilation (15%). Most cases required PICU admission (75%) and inotropic support (57%), with the rare need for extracorporeal membrane oxygenation (4%). Almost all of these children wholly recovered in a few days, although rare deaths have been reported (2%). Out of PMIS cases we ide...

show abstract

Section: Resultsmentioning

confidence: 99%

Cardiovascular impact of COVID-19 with a focus on children: A systematic review

Rodríguez-González

Castellano-Martínez

Cascales-Poyatos³

et al. 2020

WJCC

View full text Add to dashboard Cite

show abstract

“…These issues and questions related to them are central to our ability to provide care for our patients. 1 As a sequel to our previous review, the purpose of this review is to succinctly summarize our current understanding of frequently asked questions regarding COVID-19 with respect to congenital heart disease. 2 Some of these questions were included in the previous review, but updated information has become available.…”

Section: Introductionmentioning

confidence: 99%

“…As always, clinical judgment on urgent or emergent need for procedure requires diligence on the part of the cardiothoracic surgeon and cardiologist. 1 , 10 https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-hospitalized-patients.html https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307004/ https://pubmed.ncbi.nlm.nih.gov/32662334/ …”

Section: Introductionmentioning

confidence: 99%

COVID-19: FAQs in Pediatric Cardiac Surgery—A Sequel

Levy

Blumenthal

Chiotos

et al. 2020

World J Pediatr Congenit Heart Surg

Self Cite

View full text Add to dashboard Cite

“…As programs across the nation cautiously reactivate, this must be done while monitoring for local COVID-19 resurgence and/or institutional resource limitations that may require reversion back to a surgical prioritization strategy. 6 Finally, while the prevalence of COVID-19 in congenital cardiac surgery patients is very low, universal preoperative COVID-19 testing should be continued, with rare exceptions, as recommended by our governing societies. 2,6 Authors' Note…”

mentioning

confidence: 99%

“…6 Finally, while the prevalence of COVID-19 in congenital cardiac surgery patients is very low, universal preoperative COVID-19 testing should be continued, with rare exceptions, as recommended by our governing societies. 2,6 Authors' Note…”

mentioning

confidence: 99%